A video summary on how well-nourished patients are better able to tolerate and complete their antineoplastic therapy and experience better outcomes, including improved quality of life and survival. Early identification of patients with cancer commencing or undergoing antineoplastic therapy who are at nutritional risk is critical for optimizing treatment success. PRONTO (Protocol for Nutritional Risk in Oncology) provides a standardized approach for healthcare professionals treating patients with cancer to quickly identify those with or at risk of malnutrition and/or low strength or mobility for further evaluation and follow-up with members of the multidisciplinary care team.
The original article, " Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)," was published in Cancers in January 2023. Muscaritoli M, Bar-Sela G, Battisti NML, et al. Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO). Cancers (Basel). 2023;15(2):380. doi:10.3390/cancers15020380